PetCaseFinder

Peer-reviewed veterinary case report

Detecting alkaline phosphatase in stained dog tumor cells to identify

By Ryseff, Julia K & Bohn, Andrea A·Published in Veterinary clinical pathology·2012·Department of Microbiology, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Detection of alkaline phosphatase in canine cells previously stained with Wright-Giemsa and its utility in differentiating osteosarcoma from other mesenchymal tumors.

Species:
dog
OsteosarcomaMovement & jointsDogs

Plain-English summary

A study looked at how well a specific test could help identify osteosarcoma, a common bone cancer in dogs, by checking for alkaline phosphatase (ALP) in cells from tumor samples. Researchers found that out of 17 confirmed cases of osteosarcoma, 15 showed ALP expression, while only 4 out of 66 other types of tumors did. This means the test was quite effective, with an 88% chance of correctly identifying osteosarcoma and a 94% chance of correctly identifying other tumors. This method could help vets diagnose osteosarcoma more accurately using previously stained samples.

People also search for: dog osteosarcoma symptoms · alkaline phosphatase test for dogs · how to diagnose bone cancer in dogs

Abstract

BACKGROUND: Osteosarcoma (OSA) is a common primary bone tumor in dogs. Demonstration of alkaline phosphatase (ALP) reactivity by tumor cells on unstained slides is useful in differentiating osteosarcoma from other types of sarcoma. However, unstained slides are not always available. OBJECTIVES: The objectives of this study were to evaluate the diagnostic utility of detecting ALP expression in differentiating osteosarcoma from other sarcomas in dogs using cytologic material previously stained with Wright-Giemsa stain and to assess the sensitivity and specificity of ALP expression for diagnosing osteosarcoma using a specific protocol. METHODS: Archived aspirates of histologically confirmed sarcomas in dogs that had been previously stained with Wright-Giemsa stain were treated with 5-bromo, 4-chloro, 3-indolyl phosphate/nitroblue tetrazolium (BCIP/NBT) as a substrate for ALP. Cells were evaluated for expression of ALP after incubation with BCIP/NBT for 1 hour. Sensitivity and specificity of ALP expression for diagnosis of OSA were calculated. RESULTS: In samples from 83 dogs, cells from 15/17 OSAs and from 4/66 tumors other than OSA (amelanotic melanoma, gastrointestinal stromal tumor, collision tumor, and anaplastic sarcoma) expressed ALP. Sensitivity and specificity of ALP expression detected using BCIP/NBT substrate applied to cells previously stained with Wright-Giemsa stain for OSA were 88 and 94%, respectively. CONCLUSIONS: ALP expression detected using BCIP/NBT substrate applied to previously stained cells is useful in differentiating canine OSA from other mesenchymal neoplasms.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/22676437/